Sida i infecció per VIH
Publicacions destacades
-
Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells.
Moraga E; Climent N; Sánchez-Molina A; Vicens-Artés S; Maleno MJ;(...)Miró JM; Mallolas J; Albendín-Iglesias H; Alcamí J; Sánchez-Palomino S.Referència:PLoS Pathogens 2026.
-
Atypical Hepatitis B Virus Serological Patterns After Switching to Long-Acting Cabotegravir/Rilpivirine: Interpretation Within Current Definitions
Foncillas, A; Ambrosioni, J; de la Mora, L; Mallolas, J; González-Cordón, A;Laguno, M.Referència:CLINICAL INFECTIOUS DISEASES 2026.
-
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial).
Ambrosioni J; de Lazzari E; Sánchez-Palomino S; Bailón L; Suanzes P;(...)Vicens-Artés S; Moraga E; Cruceta A; Mallolas J; Miró JM.Referència:JOURNAL OF INFECTION 2025.
-
Results of a fast-track HIV and hepatitis C screening protocol in Barcelona, Spain
Chivite, I; Guilera, V; Callau, P; Aguiló, R; de Lazzari, E;Merino, MJ; Diaz, L; Carrodeguas, A; González-Sánchez, JL; Mallolas, J.Referència:PLoS One 2025.
-
Long-Term Health Outcomes of People with HIV Engaged in Chemsex: A Prospective Cohort Study on Drug Use, Sexual Behaviour, Sexually-Transmitted Infections and Vulnerability
De la Mora, Lorena; Laguno, Montserrat; Torres, Berta; Chivite, Ivan; Foncillas, Alberto;(...)Miquel, Laia; Blanch, Jordi; Short, Duncan; Mallolas, Josep; Martinez-Rebollar, Maria.Referència:Infectious Diseases and Therapy 2025.
-
Effectiveness and Safety of Bictegravir/ Emtricitabine/Tenofovir Alafenamide in People with HIV: A Real-World Data from the Spanish BICSTaR Cohort
Inciarte, Alexy; Miralles, Celia; Silva-Klug, Ana; Revollo, Boris; Deltoro, Miguel Garcia;(...)Carracedo, Manuel Angel Castano; De Alvaro, Cristina; Ramroth, Johanna; Gonzalez-Cordon, Ana; Mallolas, Josep.Referència:HIV/AIDS - Research and Palliative Care 2025.
-
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations
Inciarte, Alexy; de la Mora, Lorena; Huaier-Arriazu, Emilio; Torres, Berta; Canizares, Silvia;(...)Martinez, Esteban; Blanco, Jose Luis; Miro, J M; Martinez-Rebollar, Maria; Mallolas, Josep.Referència:Infectious Diseases and Therapy 2024.
-
Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020
Toyos, S; Berrocal, L; González-Cordó, A; Inciarte, A; de la Mora, L;(...)Blanco, JL; Martínez, E; Miró, JM; Mallolas, J; Torres, B.Referència:Eurosurveillance 2023.
-
PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement
Laguno, M; Ugarte, A; Martinez-Rebollar, M; Sobrino, Y; Font, G;(...)Rojas, J; Cordón, E; Blanco, JL; Martínez, E; Mallolas, J.Referència:ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2023.
-
Immunological and virological findings in a patient with exceptional post-treatment control: a case report
Climent, N; Ambrosioni, J; González, T; Xufré, C; Casadellà, M;(...)Grau-Expósito, J; Mallolas, J; Alcamí, J; Sánchez-Palomino, S; Miró, JM.Referència:Lancet HIV 2023.
